Abstract:Background: Gastric cancer is a common malignant tumor of the digestive system worldwide, and its early diagnosis is crucial to improve the survival rate of patients. Indocyanine green fluorescence imaging (ICG-FI), as a new imaging technology, has shown potential application prospects in oncology surgery. The meta-analysis to study the application value of ICG-FI in the diagnosis of gastric cancer sentinel lymph node biopsy is helpful to comprehensively evaluate the clinical effect of this technology and provide more reliable guidance for clinical practice. Aim: To assess the diagnostic efficacy of optical imaging in conjunction with indocyanine green (ICG)-guided sentinel lymph node (SLN) biopsy for gastric cancer. Methods: Electronic databases such as PubMed, Embase, Medline, Web of Science, and the Cochrane Library were searched for prospective diagnostic tests of optical imaging combined with ICG-guided SLN biopsy. Stata 12.0 software was used for analysis by combining the "bivariable mixed effect model" with the "midas" command. The true positive value, false positive value, false negative value, true negative value, and other information from the included literature were extracted. A literature quality assessment map was drawn to describe the overall quality of the included literature. A forest plot was used for heterogeneity analysis, and P < 0.01 was considered to indicate statistical significance. A funnel plot was used to assess publication bias, and P < 0.1 was considered to indicate statistical significance. The summary receiver operating characteristic (SROC) curve was used to calculate the area under the curve (AUC) to determine the diagnostic accuracy. If there was interstudy heterogeneity (I 2 > 50%), meta-regression analysis and subgroup analysis were performed. Results: Optical imaging involves two methods: Near-infrared (NIR) imaging and fluorescence imaging. A combination of optical imaging and ICG-guided SLN biopsy was useful for diagnosis. The positive likelihood ratio was 30.39 (95%CI: 0.92-1.00), the sensitivity was 0.95 (95%CI: 0.82-0.99), and the specificity was 1.00 (95%CI: 0.92-1.00). The negative likelihood ratio was 0.05 (95%CI: 0.01-0.20), the diagnostic odds ratio was 225.54 (95%CI: 88.81-572.77), and the SROC AUC was 1.00 (95%CI: The crucial values were sensitivity = 0.95 (95%CI: 0.82-0.99) and specificity = 1.00 (95%CI: 0.92-1.00). The Deeks method revealed that the "diagnostic odds ratio" funnel plot of SLN biopsy for gastric cancer was significantly asymmetrical (P = 0.01), suggesting significant publication bias. Further meta-subgroup analysis revealed that, compared with fluorescence imaging, NIR imaging had greater sensitivity (0.98 vs 0.73). Compared with optical imaging immediately after ICG injection, optical imaging after 20 minutes obtained greater sensitivity (0.98 vs 0.70). Compared with that of patients with an average SLN detection number < 4, the sensitivity of patients with a SLN detection number ≥ 4 was greater (0.96 vs 0.68). Compared with hematoxylin-eosin (HE) staining, immunohistochemical (+ HE) staining showed greater sensitivity (0.99 vs 0.84). Compared with subserous injection of ICG, submucosal injection achieved greater sensitivity (0.98 vs 0.40). Compared with 5 g/L ICG, 0.5 and 0.05 g/L ICG had greater sensitivity (0.98 vs 0.83), and cT1 stage had greater sensitivity (0.96 vs 0.72) than cT2 to cT3 clinical stage. Compared with that of patients ≤ 26, the sensitivity of patients > 26 was greater (0.96 vs 0.65). Compared with the literature published before 2010, the sensitivity of the literature published after 2010 was greater (0.97 vs 0.81), and the differences were statistically significant (all P < 0.05). Conclusion: For the diagnosis of stomach cancer, optical imaging in conjunction with ICG-guided SLN biopsy is a therapeutically viable approach, especially for early gastric cancer. The concentration of ICG used in the SLN biopsy of gastric cancer may be too high. Moreover, NIR imaging is better than fluorescence imaging and may obtain higher sensitivity.

A Novel Approach for the Detection of Early Gastric Cancer: Fluorescence Spectroscopy of Gastric Juice

The Intrinsic Fluorescence Spectrum of Dilute Gastric Juice As a Novel Diagnostic Tool for Gastric Cancer.

Clinical Study on the Value of Gastric Juice Autofluorescence Spectra, pH and Occult Blood Test in the Diagnosis of Gastric Cancer

A Novel Detection Technology for Early Gastric Cancer Based on Raman Spectroscopy.

A Novel Gastric Juice Index Model For Detecting Early Gastric Cancer

The diagnostic value of gastric juice autofluorescence spectrum in gastric carcinoma with a standardized detecting method

[The Value of Autofluorescence Spectrum Analysis of Gastric Juice in Diagnosing Gastric Carcinoma: a Preliminary Result].

Study on autofluoresecence spectrum of gastric juice in clinical screening for gastric cancer

High Levels of Aromatic Amino Acids in Gastric Juice During the Early Stages of Gastric Cancer Progression

[Study of Autofluorescence Spectrum of Dilute Gastric Juice in the Diagnosis of Gastric Carcinoma].

Application value of indocyanine green fluorescence imaging in guiding sentinel lymph node biopsy diagnosis of gastric cancer: Meta-analysis

A New Method for Early Screening of Gastric Cancer (G17 and CA724 Dual-Labeled Time-Resolved Fluorescence Immunoassay)

Three aromatic amino acids in gastric juice as potential biomarkers for gastric malignancies.

Detection of Digestive Malignancies and Post-Gastrectomy Complications Via Gastrointestinal Fluid Examination

Small molecules as potential biomarkers of early gastric cancer: A mass spectrometry imaging approach

Comparative Study of Testing Parameters in Measuring Autofluorescence Spectrum of Gastric Juice for Detection of Malignant Gastric Lesion

Diagnosis of Early Gastric Cancer Based on Fluorescence Hyperspectral Imaging Technology Combined with PLS-DA and SVM.

Fecal Signatures of Streptococcus anginosus and Streptococcus constellatus for Noninvasive Screening and Early Warning of Gastric Cancer

Diagnosis of early gastric cancer based on fluorescence hyperspectral imaging technology combined with partial‐least‐square discriminant analysis and support vector machine

Free Amino Acid Profiling Of Gastric Juice As A Method For Discovering Potential Biomarkers Of Early Gastric Cancer

Clinical Study of Autofluorescence Imaging Combined with Narrow Band Imaging in Diagnosing Early Gastric Cancer and Precancerous Lesions.